Australia Stock Exchange release from RHINOMED : R & D refund
15/02/2022 21:06
Australia Stock Exchange release from RHINOMED RNO.AX : R & D refund
Recent news on Rhinomed
See all newsBrief: Rhinomed Says Q2 Revenues Of A$1.8M
Australia's Rhinomed hits record low after delisting and capital raise announcement
Brief: Rhinomed Formally Applies To ASX Requesting Removal From Official List
Brief: Rhinomed Ltd Seeks Trading Halt
Brief: Rhinomed Says It Is Implementing Measures To Reduce Cash Burn, Including Reduction In Headcount